Butofilolol
Systematic (IUPAC) name | |
---|---|
(RS)-1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one | |
Identifiers | |
CAS Number | 64552-17-6 |
ATC code | none |
PubChem | CID 68838 |
ChemSpider | 62071 |
UNII | 4AZC6Y5A8G |
ChEMBL | CHEMBL157443 |
Synonyms | CM-6805 |
Chemical data | |
Formula | C17H26FNO3 |
Molar mass | 311.392 g/mol |
| |
| |
(what is this?) (verify) |
Butofilolol (trade name Cafide) is a beta-blocker drug for the treatment of essential hypertension (high blood pressure).[1][2] It is not known to be marketed anywhere.
References
- ↑ Houin, G; Barre, J; Jeanniot, JP; Ledudal, P; Cautreels, W; Tillement, JP (1984). "Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man". International journal of clinical pharmacology research 4 (3): 175–83. PMID 6149195.
- ↑ Toussain, P; Gay, G; Debry, G (1983). "Long-term hypotensive treatment by butofilolol". Annales de cardiologie et d'angeiologie 32 (4): 277–83. PMID 6412614.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.